Guardian Pharmacy Services (GRDN) Stock Forecast, Price Target & Predictions
GRDN Stock Forecast
Guardian Pharmacy Services (GRDN) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $43.50, with a high of $47.00 and a low of $40.00. This represents a 5.58% increase from the last price of $41.20.
GRDN Stock Rating
Guardian Pharmacy Services stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
GRDN Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Guardian Pharmacy Services | 5.58% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Medical Care Facilities Stocks | 10.79% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 7 |
| Avg Price Target | - | $47.00 | $36.43 |
| Last Closing Price | $41.20 | $41.20 | $41.20 |
| Upside/Downside | - | 14.08% | -11.58% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Jul, 26 | 1 | 5 | - | - | - | 6 |
| Jun, 26 | 1 | 5 | - | - | - | 6 |
| May, 26 | 1 | 5 | - | - | - | 6 |
| Apr, 26 | 1 | 4 | - | - | - | 5 |
| Mar, 26 | 1 | 3 | - | - | - | 4 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Truist Financial | $47.00 | $42.42 | 10.80% | 14.08% | |
| Mar 12, 2026 | John Ransom | Raymond James | $40.00 | $33.27 | 20.23% | -2.91% |
| Mar 12, 2026 | David MacDonald | Truist Financial | $38.00 | $34.47 | 10.24% | -7.77% |
| Jan 14, 2026 | Raj Kumar | Stephens | $36.00 | $31.26 | 15.16% | -12.62% |
| Nov 14, 2025 | Truist Financial | $34.00 | $29.51 | 15.22% | -17.48% | |
| Oct 10, 2025 | Oppenheimer | $30.00 | $23.68 | 26.69% | -27.18% | |
| Sep 26, 2025 | David MacDonald | Truist Financial | $30.00 | $25.68 | 16.82% | -27.18% |
| May 14, 2025 | John Ransom | Raymond James | $28.00 | $24.12 | 16.09% | -32.04% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Mar 12, 2026 | Raymond James | Outperform | Outperform | hold |
| Mar 12, 2026 | UBS | Buy | Buy | hold |
| Jan 14, 2026 | Stephens | Overweight | Overweight | hold |
| Oct 10, 2025 | Oppenheimer | Outperform | initialise | |
| May 14, 2025 | Raymond James | Outperform | Outperform | hold |
Financial Forecast
EPS Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $-1.77 | $0.79 | - | - |
| Avg Forecast | $0.19 | $0.94 | $1.05 | $1.08 |
| High Forecast | $0.19 | $0.98 | $1.09 | $1.08 |
| Low Forecast | $0.19 | $0.85 | $1.00 | $1.08 |
| Surprise % | -1031.58% | -15.96% | - | - |
Revenue Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $1.23B | $1.45B | - | - |
| Avg Forecast | $1.22B | $1.34B | $1.38B | $1.51B |
| High Forecast | $1.23B | $1.34B | $1.38B | $1.51B |
| Low Forecast | $1.22B | $1.34B | $1.37B | $1.51B |
| Surprise % | 0.43% | 8.03% | - | - |
Net Income Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $-87.29M | $49.22M | - | - |
| Avg Forecast | $11.99M | $56.90M | $64.80M | $66.97M |
| High Forecast | $12.02M | $61.06M | $67.59M | $67.15M |
| Low Forecast | $11.95M | $52.73M | $62.01M | $66.78M |
| Surprise % | -828.15% | -13.50% | - | - |